View by Specialty

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

Headline News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 11, 2024
2 min read
Save

Cadonilimab regimen extends survival in advanced cervical cancer

Cadonilimab regimen extends survival in advanced cervical cancer

The addition of cadonilimab to first-line chemotherapy improved outcomes among certain women with cervical cancer.

SPONSORED CONTENT
November 11, 2024
1 min watch
Save

VIDEO: Ocular Therapeutix shifts to retina-focused treatments

VIDEO: Ocular Therapeutix shifts to retina-focused treatments

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses the company’s shift to a retina-focused program.

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

SPONSORED CONTENT
November 11, 2024
3 min read
Save

OSA more prevalent in Black, Native Americans, less prevalent in Asians

OSA more prevalent in Black, Native Americans, less prevalent in Asians

BOSTON — Black and Native American adults had elevated prevalences of obstructive sleep apnea vs. non-Hispanic white adults, and Asian adults had a low prevalence, according to data presented at the CHEST Annual Meeting.

SPONSORED CONTENT
November 11, 2024
2 min read
Save

Exacerbation, hospitalization rates smaller with use vs. no use of metformin in COPD

Exacerbation, hospitalization rates smaller with use vs. no use of metformin in COPD

BOSTON — Among adults with COPD, the odds for exacerbations and hospitalizations were elevated in patients who did not use vs. did use the diabetes medication metformin, according to an abstract presented at the CHEST Annual Meeting.

SPONSORED CONTENT
November 11, 2024
3 min read
Save

Zegocractin ‘holds promise’ for reducing organ failure, necrosis in acute pancreatitis

Zegocractin ‘holds promise’ for reducing organ failure, necrosis in acute pancreatitis

PHILADELPHIA —Higher doses of zegocractin significantly reduced severe organ failure and necrotizing pancreatitis in patients with acute pancreatitis and systemic inflammatory response syndrome, according to late-breaking data.

SPONSORED CONTENT
November 11, 2024
4 min read
Save

Combination reduces agitated delirium among patients with advanced cancers

Combination reduces agitated delirium among patients with advanced cancers

The addition of lorazepam to haloperidol reduced symptoms of agitated delirium among individuals with advanced cancers, according to study findings.

SPONSORED CONTENT
November 11, 2024
2 min read
Save

Rheumatic disease activity at time of COVID-19 vaccination drives subsequent flare risk

Rheumatic disease activity at time of COVID-19 vaccination drives subsequent flare risk

Higher disease activity and medication reduction at COVID-19 vaccination increase the risk for subsequent flares in patients with rheumatic and musculoskeletal diseases, according to data published in Annals of the Rheumatic Diseases.

SPONSORED CONTENT
November 11, 2024
2 min read
Save

Single-fraction SBRT confers ‘surprisingly excellent’ outcomes for central lung tumors

Single-fraction SBRT confers ‘surprisingly excellent’ outcomes for central lung tumors

Single-fraction stereotactic body radiation therapy may be an effective treatment for individuals with central lung cancer, according to prospective study results presented at American Society for Radiation Oncology Annual Meeting.

SPONSORED CONTENT
November 11, 2024
4 min watch
Save

VIDEO: Immunotherapy ‘main focus in the field’ of acute lymphoblastic leukemia

VIDEO: Immunotherapy ‘main focus in the field’ of acute lymphoblastic leukemia

Healio spoke with John Molina, MD, MEd, about research updates on the use of immunotherapy in leukemia from this year’s Society of Hematologic Oncology Annual Meeting.

SPONSORED CONTENT
November 10, 2024
2 min read
Save

Roflumilast cream 0.15% addresses unmet needs of adults, children with atopic dermatitis

Roflumilast cream 0.15% addresses unmet needs of adults, children with atopic dermatitis

Roflumilast cream 0.15% showed high efficacy rates among patients aged 6 years and older with mild to moderate atopic dermatitis, according to a study.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails